IM
Healthcare & Life Sciences
Imbruvica
United Stateswww.imbruvica.com
Imbruvica is a Healthcare & Life Sciences startup based in the United States.
Active
About Imbruvica
Imbruvica is a company headquartered in the United States. Brouky classifies it under Healthcare & Life Sciences.
Imbruvica (ibrutinib) is a pharmaceutical drug developed and marketed by AbbVie used to treat certain blood cancers including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and Waldenström's macroglobulinemia (WM).
Explore Imbruvica's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.